COHERENCE Patents
COHERENCE is licensing US patent #7922664: Method And System For Improving Physiologic Health Via Assessment Of The Dynamic Respiratory Arterial Pressure Wave Using Plethysmographic Technique
Using this COHERENCE patent, a business entity may develop an instrument to observe and feed back the blood wave induced by breathing. Valsalva Wave Pro is the COHERENCE instantiation of the invention. Visit www.valsalvawave.com to find out more.
License terms:
License entitles 1 business entity to employ intellectual property of this patent in one or more products for the life of the patent.
1) One time non-refundable payment of $5000 (five thousand US dollars) at the time of license purchase.
2) Royalty paid to COHERENCE LLC of $10 (ten US dollars) per product manufactured for the life of the patent. Production volumes of the product or products incorporating this patent must be reported to COHERENCE LLC and $10 (ten US dollars) per unit manufactured remitted by April 15th each year after license purchased or when sum exceeds $1000 (one thousand US dollars) and thereafter when sum exceeds $1000 (one thousand US dollars).
The company name must be provided with purchase.
Purchase is final.
License document, authorized by both parties, and receipt of payment serve as evidence of license.
The license is not transferrable.
The license is not exclusive.
Legal disputes occur in The State Of Texas.
This concludes the terms.
No other terms are granted or implied.
End
To inquire call or email COHERENCE Customer Service:
866-441-0707
April 12th, 2011– COHERENCE is awarded US Patent #7922664: Method And System For Improving Physiologic Status And Health Via Assessment Of The Dynamic Respiratory Arterial Pressure Wave Using The Plethysmographic Technique.
This patent specifies the method and system of monitoring and feedback of the respiratory arterial pressure wave in biofeedback applications. It is a primary aspect of the intellectual property underlying COHERENCE Valsalva Wave Pro and BreatheHeart biofeedback instruments.
CHICAGO, Feb. 17, 2011 /PRNewswire/ — The method represented in the Coherence L.L.C. patent integrates the measurement of a respiratory arterial pressure wave (a blood wave that rises and falls with exhalation and inhalation) into conventional blood pressure readings to provide healthcare professionals and users with diagnostic information regarding breathing effectiveness and its effect on systemic blood pressure.
December 9th, 2010 – COHERENCE announces the notice of allowance of patent application 11/732,819: Method And System For Improving Physiologic Status And Health Via Assessment Of The Dynamic Respiratory Arterial Pressure Wave Using The Plethysmographic Technique
This patent specifies the method and system of monitoring and feedback of the respiratory arterial pressure wave in biofeedback applications. It is a primary aspect of the intellectual property underlying COHERENCE Valsalva Wave Pro and BreatheHeart biofeedback instruments.
May 11th, 2010 – COHERENCE LLC is awarded US Patent #7713212: Method and system for consciously synchronizing the breathing cycle with the natural heart rate cycle.
This patent generates biofeedback signals at heart rate peaks and valleys and instructs the user to exhale at peaks and inhale at valleys.
This method of training results in conscious synchrony of breathing with the autonomic response to breathing, i.e. rising and falling blood volume. In this way we are able to synchronize conscious somatic action of the body with the unconscious autonomic activity, yielding optimal coherence and homeostasis.
December 2, 2008 – COHERENCE LLC is awarded US Patent #7458937: Method and system for assessing breathing effectiveness via assessment of the dynamic arterial pressure wave using the oscillometric measurement technique.
This patent asserts the method of detection and measurement of the respiratory arterial pressure wave during oscillometric blood pressure measurement. In this way, the user or health professional can determine the magnitude of the pressure wave (1-30 mmHg) and counsel the client to improve their breathing in order to reduce their systemic blood pressure. (The invention assumes that the primary cause of essential hypertension is sub-optimal breathing and the general absense of the respiratory arterial pressure wave component in most adults.)
March 25, 2008 – COHERENCE LLC is awarded US Patent #7349194: Method and system for electrically connecting the human organism to Earth so as to facilitate an electrical current between the human biopotential and earth for the purpose of promoting health, well-being, and performance.
This patent asserts that the human organism desires electrical connectedness to Earth and that varying the connectivity between the body and Earth results in variation of the internal impedance of the human body such that current flow between the body and Earth can modulated – current flow peaking at ~200 ohms, this representing the human body’s “characteristic impedance”. (Note that this patent specifies ~470 ohms, but this was later determined to be incorrect, the error being due to using the AC electrical ground vs. a dedicated biological ground. This error is thought to be a function of noise from the AC power grid being coupled into the system and the measurement. Please see this document for more explanation: Characterization_of_Impedance&Current.pdf
December 25, 2007 – COHERENCE LLC is awarded US Patent #7311658: Method and system providing a fundamental musical interval for heart rate variability synchronization.
This patent describes musical intervals that comply with a fundamental interval of 5.88 seconds, around which “music to breathe to” can be composed.
